JCOTR | 3 HOT-OFF-THE-PRESS ARTICLES REVIEWED! 🏃 🏃♀️
All 3 of our papers these papers tackle a familiar question: can acting earlier prevent trouble later? From preventing haemorrhage to planning birth and prescribing metformin, this edition puts some familiar interventions under the microscope.
• First up, tranexamic acid. We know it earns its place when postpartum haemorrhage strikes, but can giving it before bleeding starts help women at particularly high risk? A team across 24 maternity centres in China tested just that in women undergoing caesarean birth with placenta praevia or a low-lying placenta. These are promising findings for a group that previous trials have too often left out.
• Next, we revisit a decision that keeps obstetricians on their toes: when to recommend birth for women with hypertension in pregnancy. An updated Cochrane review brings together six randomised trials comparing planned early birth with expectant management from 34 weeks. The findings strengthen the case for maternal benefits and for babies, some uncertainties remain.
• And finally, can metformin prevent gestational diabetes in women at high metabolic risk? Researchers pooled individual participant data from seven trials to find out. The answer depends partly on which diagnostic criteria you use, but the findings may also point to new neonatal benefits.
Happy reading! And don’t forget – JCOTR will be presenting at GOU2026 next week! Online tickets still available.
#MercyPerinatal #JournalClubOnTheRun #JCOTR
All 3 of our papers these papers tackle a familiar question: can acting earlier prevent trouble later? From preventing haemorrhage to planning birth and prescribing metformin, this edition puts some familiar interventions under the microscope.
• First up, tranexamic acid. We know it earns its place when postpartum haemorrhage strikes, but can giving it before bleeding starts help women at particularly high risk? A team across 24 maternity centres in China tested just that in women undergoing caesarean birth with placenta praevia or a low-lying placenta. These are promising findings for a group that previous trials have too often left out.
• Next, we revisit a decision that keeps obstetricians on their toes: when to recommend birth for women with hypertension in pregnancy. An updated Cochrane review brings together six randomised trials comparing planned early birth with expectant management from 34 weeks. The findings strengthen the case for maternal benefits and for babies, some uncertainties remain.
• And finally, can metformin prevent gestational diabetes in women at high metabolic risk? Researchers pooled individual participant data from seven trials to find out. The answer depends partly on which diagnostic criteria you use, but the findings may also point to new neonatal benefits.
Happy reading! And don’t forget – JCOTR will be presenting at GOU2026 next week! Online tickets still available.
#MercyPerinatal #JournalClubOnTheRun #JCOTR